Invacare (NYSE:IVC) will be issuing its quarterly earnings data after the market closes on Wednesday, February 13th. Analysts expect the company to announce earnings of ($0.39) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Shares of Invacare stock opened at $5.01 on Tuesday. The company has a market cap of $167.66 million, a P/E ratio of -2.60 and a beta of 2.01. Invacare has a 12 month low of $3.05 and a 12 month high of $20.00. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.05 and a quick ratio of 1.34.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 17th. Stockholders of record on Friday, January 4th were paid a $0.0125 dividend. This represents a $0.05 annualized dividend and a dividend yield of 1.00%. The ex-dividend date was Thursday, January 3rd. Invacare’s payout ratio is -2.59%.
Several equities research analysts have recently issued reports on IVC shares. Needham & Company LLC started coverage on Invacare in a research note on Thursday, January 24th. They issued a “buy” rating and a $15.00 price objective for the company. Zacks Investment Research raised Invacare from a “sell” rating to a “hold” rating in a research note on Wednesday, October 17th. Finally, ValuEngine raised Invacare from a “sell” rating to a “hold” rating in a research note on Wednesday, January 2nd. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $19.33.
In related news, Director Clifford D. Nastas acquired 9,000 shares of the stock in a transaction dated Monday, November 19th. The stock was acquired at an average cost of $5.42 per share, with a total value of $48,780.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Kathleen P. Leneghan acquired 6,500 shares of the stock in a transaction dated Tuesday, November 20th. The stock was bought at an average cost of $5.52 per share, with a total value of $35,880.00. Following the completion of the purchase, the vice president now directly owns 45,416 shares in the company, valued at $250,696.32. The disclosure for this purchase can be found here. 2.10% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Invacare (IVC) Set to Announce Earnings on Wednesday” was originally published by Transcript Daily and is owned by of Transcript Daily. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://transcriptdaily.com/2019/02/12/invacare-ivc-set-to-announce-earnings-on-wednesday.html.
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific.
Further Reading: Stock Symbol
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.